☰

Katie L. Propst, Ph.D.

Affiliations: 
2011 Microbiology, Immunology, & Pathology Colorado State University, Fort Collins, CO 
Area:
Microbiology Biology, Immunology
Google:
"Katie Propst"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Herbert P. Schweizer grad student 2011 Colorado State
 (The analysis of Burkholderia pseudomallei virulence and efficacy of potential therapeutics.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kvitko BH, Goodyear A, Propst KL, et al. (2012) Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis. Plos Neglected Tropical Diseases. 6: e1715
Norris MH, Propst KL, Kang Y, et al. (2011) The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice. Infection and Immunity. 79: 4010-8
Whitlock GC, Deeraksa A, Qazi O, et al. (2010) Protective response to subunit vaccination against intranasal Burkholderia mallei and B. pseudomallei challenge. Procedia in Vaccinology. 2
Propst KL, Mima T, Choi KH, et al. (2010) A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists. Infection and Immunity. 78: 3136-43
Propst KL, Troyer RM, Kellihan LM, et al. (2010) Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection. Antimicrobial Agents and Chemotherapy. 54: 1785-92
Trunck LA, Propst KL, Wuthiekanun V, et al. (2009) Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand. Plos Neglected Tropical Diseases. 3: e519
Troyer RM, Propst KL, Fairman J, et al. (2009) Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis Vaccine. 27: 4424-4433
Goodyear A, Kellihan L, Bielefeldt-Ohmann H, et al. (2009) Protection from pneumonic infection with burkholderia species by inhalational immunotherapy. Infection and Immunity. 77: 1579-88
Schweizer HP, Hoang TT, Propst KL, et al. (2001) Vector design and development of host systems for Pseudomonas. Genetic Engineering. 23: 69-81
See more...